|
|
||||||||
a Division of Cardiothoracic Surgery, The Ohio State University, Columbus, Ohio
b Division of Surgical Oncology, Department of Surgery, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio
c Division of Nuclear Medicine, Department of Radiology, The Ohio State University, Columbus, Ohio
Accepted for publication March 14, 2008.
* Address correspondence to Dr Moffatt-Bruce, Division of Cardiothoracic Surgery, The Ohio State University, N839 Doan Hall, 410 West 10th Ave, Columbus, OH 43210 (Email: susan.moffatt-bruce{at}osumc.edu).
18F-fluorodeoxyglucose positron emission tomography–computed tomography is integral to the staging of lung cancer. We describe the combined use of diagnostic preoperative 18F-fluorodeoxyglucose positron emission tomography–computed tomography, intraoperative 18F-fluorodeoxyglucose handheld gamma probe detection, and immediate postoperative 18F-fluorodeoxyglucose positron emission tomography–computed tomography patient and specimen imaging for improved staging and determination of adequacy of mediastinal lymph node dissection.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |